AGP Picks
View all

Onsera Health hires Sona Chandra as chief product and technology officer

11 hours ago
By AI, Created 11:00 UTC, Sep 01, 2026, AGP -

Onsera Health named healthcare AI leader Sona Chandra as chief product and technology officer on September 1, 2026, as the company pushes to expand its AI-native weight management and cardiometabolic care platform. The hire is meant to strengthen product, engineering, data and AI strategy for employers, health plans and labor organizations seeking measurable health and cost outcomes.

Why it matters: - Onsera Health is betting that AI-native care delivery can improve long-term weight and cardiometabolic outcomes while lowering total cost of care. - The appointment adds a senior leader with experience building regulated AI products in healthcare and life sciences. - Employers, health plans and labor organizations are looking for technology-enabled solutions that show clinical and financial results.

What happened: - Onsera Health appointed Sona Chandra as chief product and technology officer on September 1, 2026. - Chandra joins the company's executive leadership team. - Onsera Health said Chandra will lead product, engineering, data and artificial intelligence strategy. - The role supports Onsera Health's AI-native platform for personalized participant experiences and clinical decision-making.

The details: - Chandra most recently served as president of AI at Pangea Bio. - At Pangea Bio, Chandra led the design, development and scale of an end-to-end AI drug discovery platform. - Chandra also drove AI drug discovery programs and negotiated a co-discovery partnership worth more than $200 million with a top-10 dermatology company. - Before Pangea Bio, Chandra co-led the spinout of Oshi Health from Takeda Pharmaceuticals. - At Oshi Health, Chandra helped build the founding product and clinical model for the virtual gastrointestinal care company. - Oshi Health now serves more than 40 million in-network patients and has raised more than $120 million. - Earlier at Takeda, Chandra helped shape enterprise AI and digital strategy alongside the company's chief digital officer. - Chandra has also focused throughout her career on products at the intersection of artificial intelligence, healthcare and life sciences. - Onsera Health says its platform combines clinical care, personalized coaching, advanced analytics and medication management into a single connected experience. - The company says the platform is designed to deliver measurable, sustainable results. - Chandra holds a Master of Public Health from the Harvard T.H. Chan School of Public Health and a Bachelor of Science in biomedical engineering from the Georgia Institute of Technology. - Chandra serves on the board of directors for the Center for Addiction Science, Policy and Research (CASPR). - Forbes recognized Chandra in its 30 Under 30 for Healthcare & Science. - Onsera Health is an AI-native, physician-led weight management and cardiometabolic care company. - The company serves employers, health plans and labor organizations.

Between the lines: - Onsera Health is signaling that product leadership is a core part of its growth strategy, not just an operational hire. - Chandra's background suggests Onsera Health wants someone who can bridge scientific complexity, product development and commercial execution. - The focus on measurable outcomes points to a market where buyers want proof that AI improves both health and economics.

What's next: - Chandra is expected to help scale Onsera Health's AI-native platform and sharpen its care model. - Onsera Health will continue positioning its platform around personalized care, clinical support and cost reduction. - The company is aiming to expand its role in cardiometabolic care as demand for outcomes-driven solutions grows.

The bottom line: - Onsera Health is adding a proven healthcare AI product leader to accelerate its push into AI-native weight management and cardiometabolic care.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.